1 From the Cardiovascular Service, Lenox Hill Hospital, N. Y.
Sudden death and arterial embolism are unpredictable hazards of quinidine therapy for atrial fibrillation that act as deterrents to its most effective use. In this paper an attempt is made to determine the incidence of these accidents as reported in the literature. The mechanism of sudden death is also examined. The difficulty of determining the role of quinidine in producing these accidents in seriously ill patients is clarified.
© 1956 American Heart Association, Inc.
Quinidine as a Cause of Sudden Death
This article has been cited by other articles:
![]() |
M. M. Gallagher, B. J. Hennessy, N. Edvardsson, C. M. Hart, M. S. Shannon, O. A. Obel, N. M. Al-Saady, and A. J. Camm Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion J. Am. Coll. Cardiol., September 4, 2002; 40(5): 926 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sharma, P. Ott, V. Hartz, J. W. Mason, and F. I. Marcus Risk Factors for Tachycardia Events Caused by Antiarrhythmic Drugs: Experience From the ESVEM Trial Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(4): 269 - 274. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1956 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |